To assess the impact of DNGR-1 on the cancer mutational landscape, we performed whole exome sequencing of DNA extracted from primary cell lines derived from each of the tumors in one representative experiment consisting of n = 43 individual mice: DNGR-1KO (n = 14), RAG1KO (n = 11) and WT (n = 18). The gene discussed is CLEC9A; the disease is cancer.